Chin Mark 4
4 · Harpoon Therapeutics, Inc. · Filed Oct 2, 2023
Insider Transaction Report
Form 4
Chin Mark
Director10% Owner
Transactions
- Award
Common Stock
2023-10-01+3,035→ 6,729 total
Footnotes (2)
- [F1]Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.
- [F2]Shares reflect 1:10 reverse stock split effective September 1, 2023.